Clinical factors associated with growth and neoantigen reactivity of tumor infiltrating lymphocytes from metastatic epithelial cancers
Abstract Background Adoptive cell therapy with tumor infiltrating lymphocytes is FDA approved for metastatic melanoma. TIL from patients with melanoma and factors relating to growth and reactivity have been studied; however, this has not been explored in patients with epithelial cancers. Patients an...
Saved in:
| Main Authors: | Alexandra M. Gustafson, Aaron J. Dinerman, Kyle J. Hitscherich, Maria R. Parkhurst, Hyunmi Halas, Donald E. White, Chuong D. Hoang, Jonathan M. Hernandez, Mei Li M. Kwong, Nicholas D. Klemen, Steven A. Rosenberg, Stephanie L. Goff, James C. Yang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-06-01
|
| Series: | Cancer Immunology, Immunotherapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s00262-025-04091-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A pan-cancer comparative analysis of the cancer genome atlas transcriptomic TIL-immune signatures
by: Kyle J. Hitscherich, et al.
Published: (2025-08-01) -
Breaking down physical barriers: strategies to improve lymphocyte infiltration for effective neoantigen-based therapies
by: Ting-Ting Chen, et al.
Published: (2025-06-01) -
Tumor-infiltrating lymphocytes in colorectal carcinoma
by: Shovana Karki, et al.
Published: (2021-09-01) -
Meme Karsinomunda Tümörü infiltre eden T Lenfositlerin Yoğunluğunun Prognostik Faktörlerle İlişkisi
by: Mustafa Kösem, et al.
Published: (2025-06-01) -
Isolated Renal Metastasis from Neuroendocrine Tumor: How Rare is Rare? A Case Report and Review of the Literature
by: Irma Lengu, et al.
Published: (2016-03-01)